Conferences

ecancer travels so that you don't have to. Expore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

SABCS 2014

9 - 11 Dec 2014
Henry B. Gonzalez Convention Center, San Antonio, Texas, United States of America
Comment: SABCS 2014 Highlights
Prof Kent Osborne - Baylor College of Medicine, Houston, USA
Comment: SABCS 2014 Highlights ( Prof Kent Osborne -  Baylor College of Medicine, Houston, USA )
16 Dec 2014
Comment: Reducing fat intake reduces death rates in some breast cancer patients
Prof Kent Osborne - Baylor College of Medicine, Houston, USA
Comment: Reducing fat intake reduces death rates in some breast cancer patients ( Prof Kent Osborne -  Baylor College of Medicine, Houston, USA )
16 Dec 2014
Comment: Fulvestrant improves survival over anastrozole for patients with advanc...
Prof Kent Osborne - Baylor College of Medicine, Houston, USA
Comment: Fulvestrant improves survival over anastrozole for patients with advanced breast cancer ( Prof Kent Osborne -  Baylor College of Medicine, Houston, USA )
16 Dec 2014
Comment: Multigene test can predict risk of disease recurrence for women with du...
Prof Kent Osborne - Baylor College of Medicine, Houston, USA
Comment: Multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ ( Prof Kent Osborne -  Baylor College of Medicine, Houston, USA )
16 Dec 2014
Comment: BOLERO-1 reports HER2-positive breast cancer latest PFS data
Prof Kent Osborne - Baylor College of Medicine, Houston, USA
Comment: BOLERO-1 reports HER2-positive breast cancer latest PFS data ( Prof Kent Osborne -  Baylor College of Medicine, Houston, USA )
16 Dec 2014
New IMRT techniques could be tissue-sparing and promote dosage conformity in bre...
Prof Lorenzo Livi - Careggi Hospital, Florence, Italy
New IMRT techniques could be tissue-sparing and promote dosage conformity in breast cancer ( Prof Lorenzo Livi - Careggi Hospital, Florence, Italy )
16 Dec 2014
Tamoxifen lowered breast cancer rates among high-risk women
Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Tamoxifen lowered breast cancer rates among high-risk women ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
16 Dec 2014
Fulvestrant versus anastrozole in patients with advanced breast cancer
Prof John Robertson - Royal Derby Hospital, Derby, UK
Fulvestrant versus anastrozole in patients with advanced breast cancer ( Prof John Robertson - Royal Derby Hospital, Derby, UK )
16 Dec 2014
Reducing fat intake reduces death rates in some breast cancer patients
Professor Rowan Chlebowski - Harbor-UCLA Medical Centre, Torrance, USA
Reducing fat intake reduces death rates in some breast cancer patients ( Professor Rowan Chlebowski - Harbor-UCLA Medical Centre, Torrance, USA )
16 Dec 2014
Recurrence risk could be predicted by a multigene test in ductal carcinoma breas...
Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada
Recurrence risk could be predicted by a multigene test in ductal carcinoma breast cancer ( Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada )
16 Dec 2014
Breast cancer in men and women has different biological characteristics and outc...
Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal
Breast cancer in men and women has different biological characteristics and outcomes ( Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal )
15 Dec 2014
PD-1 inhibitor pembrolizumab shows promising clinical activity for triple-negati...
Dr Rita Nanda - University of Chicago Medicine, Chicago, USA
PD-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer ( Dr Rita Nanda - University of Chicago Medicine, Chicago, USA )
12 Dec 2014
Magnetic nanotechnology for the localisation of non-palpable breast cancers and ...
Dr Muneer Ahmed - Guys Hospital, London, UK
Magnetic nanotechnology for the localisation of non-palpable breast cancers and concurrent sentinel node biopsy ( Dr Muneer Ahmed - Guys Hospital, London, UK )
12 Dec 2014
Combination of eribulin and capecitabine provides clinical benefit for women wit...
Dr Chris Twelves - St James's Hospital, Leeds, UK
Combination of eribulin and capecitabine provides clinical benefit for women with metastatic breast cancer ( Dr Chris Twelves - St James's Hospital, Leeds, UK )
12 Dec 2014
Ovarian suppression with tamoxifen reduced recurrence for some women with premen...
Dr Prudence Francis - Peter MacCallum Cancer Centre, Melbourne, Australia
Ovarian suppression with tamoxifen reduced recurrence for some women with premenopausal breast cancer ( Dr Prudence Francis - Peter MacCallum Cancer Centre, Melbourne, Australia )
12 Dec 2014
Comment: Impact of combined bevacizumab and presurgery chemo varies by subtype
Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA
Comment: Impact of combined bevacizumab and presurgery chemo varies by subtype ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )
12 Dec 2014
Adding ultrasound to routine mammography improves cancer detection in dense brea...
Dr Jean Weigert - Cancer Center of Central Connecticut, New Britain, USA
Adding ultrasound to routine mammography improves cancer detection in dense breasts ( Dr Jean Weigert - Cancer Center of Central Connecticut, New Britain, USA )
12 Dec 2014
High tumour immune cell levels may help screen HER2-positive breast cancer patie...
Dr Edith Perez - Mayo Clinic, Rochester, USA
High tumour immune cell levels may help screen HER2-positive breast cancer patients for chemo ( Dr Edith Perez - Mayo Clinic, Rochester, USA )
12 Dec 2014
Comment: Combining tamoxifen with ovarian suppression reduced recurrence of some...
Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA
Comment: Combining tamoxifen with ovarian suppression reduced recurrence of some breast cancers ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )
12 Dec 2014
BOLERO-1 reports HER2-positive breast cancer latest PFS data
Prof Sara Hurvitz - University of California, Los Angeles, USA
BOLERO-1 reports HER2-positive breast cancer latest PFS data ( Prof Sara Hurvitz - University of California, Los Angeles, USA )
12 Dec 2014
Comment: Tamoxifen lowered breast cancer rates among high-risk women
Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA
Comment: Tamoxifen lowered breast cancer rates among high-risk women ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )
12 Dec 2014
Impact of adding bevacizumab to presurgery chemo for triple-negative breast canc...
Dr William Sikov - Women and Infants Hospital, Providence, USA
Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype ( Dr William Sikov - Women and Infants Hospital, Providence, USA )
12 Dec 2014
Fulvestrant improves survival over anastrozole for patients with advanced breast...
Prof John Robertson - Royal Derby Hospital, Derby, UK
Fulvestrant improves survival over anastrozole for patients with advanced breast cancer ( Prof John Robertson - Royal Derby Hospital, Derby, UK )
12 Dec 2014
Progression-free survival results from BOLERO-1 trial
Prof Sara Hurvitz - University of California, Los Angeles, USA
Progression-free survival results from BOLERO-1 trial ( Prof Sara Hurvitz - University of California, Los Angeles, USA )
12 Dec 2014
Lowering dietary fat intake reduces death rates in some women with breast cancer
Prof Rowan Chlebowski - Harbor-UCLA Medical Centre, Torrance, USA
Lowering dietary fat intake reduces death rates in some women with breast cancer ( Prof Rowan Chlebowski - Harbor-UCLA Medical Centre, Torrance, USA )
12 Dec 2014
Multigene test can predict risk of disease recurrence for women with ductal carc...
Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada
Multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ ( Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada )
12 Dec 2014
Ovarian suppression with tamoxifen reduced recurrence in some premenopausal brea...
Dr Prudence Francis - Peter MacCallum Cancer Centre, Melbourne, Australia
Ovarian suppression with tamoxifen reduced recurrence in some premenopausal breast cancer cases ( Dr Prudence Francis - Peter MacCallum Cancer Centre, Melbourne, Australia )
11 Dec 2014
Comment: Capecitabine for elderly early-stage breast cancer
Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA
Comment: Capecitabine for elderly early-stage breast cancer ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )
11 Dec 2014
Capecitabine monotherapy does not improve survival in elderly patients with earl...
Prof Gunter von Minckwitz – German Breast Group, Neu-Isenburg, Germany
Capecitabine monotherapy does not improve survival in elderly patients with early-stage breast cancer ( Prof Gunter von Minckwitz – German Breast Group, Neu-Isenburg, Germany )
11 Dec 2014
Impact of adding bevacizumab to presurgery chemo for triple-negative breast canc...
Dr William Sikov - Women and Infants Hospital, Providence, USA
Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype ( Dr William Sikov - Women and Infants Hospital, Providence, USA )
11 Dec 2014
Capecitabine monotherapy does not improve survival in elderly patients with earl...
Prof Gunter Von Minckwitz – German Breast Group, Neu-Isenburg, Germany
Capecitabine monotherapy does not improve survival in elderly patients with early-stage breast cancer ( Prof Gunter Von Minckwitz – German Breast Group, Neu-Isenburg, Germany )
11 Dec 2014
IBIS-I trial: tamoxifen lowered breast cancer rates among high-risk women
Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
IBIS-I trial: tamoxifen lowered breast cancer rates among high-risk women ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
11 Dec 2014